- Home
- TCBX vs PSTX Comparison
TCBX vs PSTX Comparison
Compare TCBX & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- PSTX
- Stock Information
- Founded
- TCBX 2008
- PSTX 2014
- Country
- TCBX United States
- PSTX United States
- Employees
- TCBX N/A
- PSTX N/A
- Industry
- TCBX Banks
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCBX Finance
- PSTX Health Care
- Exchange
- TCBX Nasdaq
- PSTX Nasdaq
- Market Cap
- TCBX 313.3M
- PSTX 274.9M
- IPO Year
- TCBX 2021
- PSTX 2020
- Fundamental
- Price
- TCBX $25.22
- PSTX $2.74
- Analyst Decision
- TCBX Buy
- PSTX Strong Buy
- Analyst Count
- TCBX 5
- PSTX 3
- Target Price
- TCBX $24.40
- PSTX $14.67
- AVG Volume (30 Days)
- TCBX 46.9K
- PSTX 322.9K
- Earning Date
- TCBX 10-23-2024
- PSTX 08-05-2024
- Dividend Yield
- TCBX N/A
- PSTX N/A
- EPS Growth
- TCBX 6.18
- PSTX N/A
- EPS
- TCBX 2.15
- PSTX N/A
- Revenue
- TCBX $151,610,000.00
- PSTX $88,462,000.00
- Revenue This Year
- TCBX N/A
- PSTX $36.53
- Revenue Next Year
- TCBX $6.16
- PSTX N/A
- P/E Ratio
- TCBX $11.74
- PSTX N/A
- Revenue Growth
- TCBX 15.33
- PSTX N/A
- 52 Week Low
- TCBX $14.09
- PSTX $1.83
- 52 Week High
- TCBX $26.38
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- TCBX 65.20
- PSTX 43.53
- Support Level
- TCBX $22.47
- PSTX $2.66
- Resistance Level
- TCBX $25.80
- PSTX $2.91
- Average True Range (ATR)
- TCBX 0.54
- PSTX 0.19
- MACD
- TCBX 0.12
- PSTX -0.00
- Stochastic Oscillator
- TCBX 82.58
- PSTX 26.44
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.